Stephanie Roberts

Stephanie Roberts has extensive work experience in the pharmaceutical industry. Stephanie started their career at ERT in 1993 as a Director of Project Management and worked there until 2004. After that, they joined Merck Serono as an Associate Director and Therapeutic Area Head for Neurodegenerative Diseases from 2004 to 2009. In 2009, Stephanie moved to Astellas Pharma as an Associate Clinical Research Director until 2012. Then, they joined Roche in 2013, where they held roles including Global Therapeutic Area Leader and PDMA Medical Excellence Leader until 2018. Since 2018, Stephanie has been working at Idorsia Pharmaceuticals Ltd as an Associate Director of Clinical Program Leader until February 2022 and currently as the Director of Global Medical Governance.

Stephanie Roberts completed their education in 2016 with a Master of Business Administration (MBA) degree in Business Administration and Management from The Open University. Prior to that, their education includes an MSc. in Pharmacology from the University of East London, although specific start and end years are not provided. In terms of certifications, Stephanie obtained a certification in Orphan Drug Drugs Clinical Trials from Symmetric Training (Professional Training & Coaching) in the year 2020.